Neogen Chemicals Limited

NSEI:NEOGEN 株式レポート

時価総額:₹46.2b

Neogen Chemicals 将来の成長

Future 基準チェック /56

Neogen Chemicals利益と収益がそれぞれ年間35.1%と27.1%増加すると予測されています。EPS は年間 増加すると予想されています。自己資本利益率は 3 年後に10.8% 34.7%なると予測されています。

主要情報

35.1%

収益成長率

34.71%

EPS成長率

Chemicals 収益成長19.4%
収益成長率27.1%
将来の株主資本利益率10.83%
アナリストカバレッジ

Good

最終更新日21 May 2026

今後の成長に関する最新情報

分析記事 Feb 06

Neogen Chemicals Limited Just Missed Earnings - But Analysts Have Updated Their Models

It's been a pretty great week for Neogen Chemicals Limited ( NSE:NEOGEN ) shareholders, with its shares surging 16% to...

Recent updates

ナラティブの更新 May 11

NEOGEN: Preferential Equity Funding Will Support Long Term Upside Potential

Analysts have trimmed their price target for Neogen Chemicals from ₹2,630 to about ₹2,311 as they factor in more moderate revenue growth assumptions, a slightly higher profit margin outlook, and a lower future P/E multiple in their models. What's in the News Board meeting scheduled for April 18, 2026, to consider allotment of 1,000,000 equity shares with face value of ₹10 at an issue price of ₹1,610 per share on a preferential basis, aggregating up to ₹1,610,000,000.
ナラティブの更新 Apr 23

NEOGEN: Equity Fundraising Plans Will Pressure Elevated Future P E Multiple

Analysts have kept their price target for Neogen Chemicals steady at ₹1,335, citing only small refinements to their discount rate, revenue growth outlook and profit margin assumptions, along with a slightly lower future P/E multiple, rather than any major shift in the investment case. What's in the News On February 11, 2026, the board met to review unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2025, and to evaluate various options for raising funds through equity and other securities in one or more tranches (company filing).
ナラティブの更新 Apr 09

NEOGEN: Future PE Reset Will Test Sustainability Of Recent Cost Improvements

Narrative Update Analysts have held the fair value estimate for Neogen Chemicals steady at ₹1,335.00 while updating assumptions on growth, margins and future P/E. This reflects recent research that cites stronger revenue and EBITDA performance, cost actions taking hold and higher external price targets in the range of roughly ₹540 to ₹1,000 equivalent.
ナラティブの更新 Mar 25

NEOGEN: Raised Guidance And Cost Actions Will Support Higher Future Earnings Quality

Narrative Update Overview The revised analyst price target for Neogen Chemicals edges slightly lower to ₹1,756.25 from ₹1,769.57. This reflects updated assumptions around the discount rate, revenue growth, profit margin, and future P/E, while staying broadly aligned with recent Street research that has cited better revenue and EBITDA prints, higher guidance, and early benefits from cost actions.
ナラティブの更新 Mar 10

NEOGEN: Future P E Compression Will Challenge Optimism Around Cost Driven Margin Gains

Our updated fair value estimate for Neogen Chemicals shifts to ₹1,335 from ₹1,670 as analysts factor in slightly adjusted growth assumptions, a modestly lower discount rate, firmer profit margins and a reduced future P/E multiple, broadly in line with recent Street research that links higher targets in other names to improving revenue quality, cost actions and guidance. Analyst Commentary Street research around Neogen Chemicals points to a more measured setup, even as some peers in the sector see higher optimism baked into targets.
ナラティブの更新 Feb 24

NEOGEN: Raised Guidance And Cost Actions Will Support Richer Future Earnings Multiple

Analysts have trimmed their fair value estimate for Neogen Chemicals from ₹1,847 to about ₹1,770, as slightly softer revenue growth and margin inputs are being offset by a higher assumed future P/E multiple and recent Street target hikes following better than expected earnings and guidance. Analyst Commentary Recent Street research around Neogen Chemicals reflects a mix of optimism about execution and some caution on how durable the current momentum might be for earnings and valuation.
ナラティブの更新 Feb 10

NEOGEN: Raised Guidance And Cost Actions Will Support Further Upside

Narrative Update: Neogen Chemicals Analysts have lifted their price target on Neogen Chemicals to a range of about $10 to $12, up from $6.50 to $8. This change is attributed to the company’s recent revenue and EBITDA beat, raised guidance, and early benefits from portfolio execution and cost actions.
ナラティブの更新 Jan 26

NEOGEN: Raised Guidance And Upcoming Board Results Will Support Upside

Narrative Update The analyst price target for Neogen Chemicals has been adjusted from approximately ₹1,812 to ₹1,847 as analysts factor in recent research that points to steady fair value assumptions, a slightly higher discount rate, unchanged growth and margin inputs, and a modestly higher future P/E multiple in light of recent earnings commentary and guidance updates on Neogen. Analyst Commentary Recent Street research on Neogen Chemicals highlights a mix of optimism around execution and guidance, paired with some restraint on how far the valuation should stretch after the latest earnings release.
ナラティブの更新 Jan 09

NEOGEN: Steady Fair Value And Upcoming Results Will Support Upside

Analysts have kept their fair value estimate for Neogen Chemicals steady at ₹1,812.29 per share, with only marginal adjustments to the discount rate, revenue growth, profit margin and future P/E inputs that are too small to materially change the target at this time. What's in the News Board meeting scheduled for November 8, 2025, at 14:30 Indian Standard Time to review and approve unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2025 (company filing).
ナラティブの更新 Dec 26

NEOGEN: Market Perform Initiation Will Support Upside From Resilient Margins

Analysts have modestly revised their price target on Neogen Chemicals upward to $10, reflecting slightly higher long term growth expectations and largely stable margin and valuation assumptions. Analyst Commentary The latest initiation at a Market Perform rating with a $10 price target highlights a balanced view on Neogen Chemicals, with analysts seeing the current valuation as broadly aligned with its near to medium term growth prospects.
ナラティブの更新 Dec 11

NEOGEN: Market Perform Initiation Will Support Steady Future Return Potential

Analysts have nudged their price target for Neogen Chemicals slightly higher, reflecting a modest improvement in fair value to roughly ₹1,812 per share. This is supported by expectations of sustained high revenue growth and stable valuation multiples, despite only minor adjustments to discount rate and profit margin assumptions.
分析記事 Dec 04

Why We're Not Concerned Yet About Neogen Chemicals Limited's (NSE:NEOGEN) 26% Share Price Plunge

The Neogen Chemicals Limited ( NSE:NEOGEN ) share price has fared very poorly over the last month, falling by a...
ナラティブの更新 Nov 27

NEOGEN: Broader Customer Base And Joint Venture Will Support Steady Future Returns

Analysts have maintained Neogen Chemicals' price target at $1,806.57, citing stable growth expectations and aligning their assessment with the recent initiation of a Market Perform rating by the Street. Analyst Commentary Bullish Takeaways Bullish analysts note Neogen Chemicals' consistent revenue growth, which supports the current valuation and underpins the stable price target.
分析記事 Nov 16

We Think That There Are More Issues For Neogen Chemicals (NSE:NEOGEN) Than Just Sluggish Earnings

Neogen Chemicals Limited's ( NSE:NEOGEN ) earnings announcement last week contained some soft numbers, disappointing...
分析記事 Nov 14

Analysts Are More Bearish On Neogen Chemicals Limited (NSE:NEOGEN) Than They Used To Be

One thing we could say about the analysts on Neogen Chemicals Limited ( NSE:NEOGEN ) - they aren't optimistic, having...
ナラティブの更新 Nov 12

NEOGEN: Product Diversification Will Drive Long-Term Returns After New Joint Venture

Analysts have revised Neogen Chemicals' fair value target downward from ₹2,062.83 to ₹1,806.57. This adjustment is due to a slightly higher discount rate and moderated revenue growth expectations, as reflected in recent research updates.
分析記事 Nov 11

These 4 Measures Indicate That Neogen Chemicals (NSE:NEOGEN) Is Using Debt Extensively

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...
ナラティブの更新 Aug 06

Expanding Lithium Battery Materials Will Secure Global Reach

Despite an upward revision in revenue growth forecasts, Neogen Chemicals’ consensus price target has been lowered to ₹2,062, primarily due to a substantial decline in its future P/E multiple. What's in the News Annual dividend decreased to INR 1 per share for FY 2024-25.
User avatar
新しいナラティブ Mar 15

Merger With BuLi Chemicals Will Strengthen Market Position In Pharma And Agrochemicals

The merger and strategic product expansions aim to strengthen Neogen's market position and boost future export and domestic revenue growth.
分析記事 Feb 21

Neogen Chemicals Limited's (NSE:NEOGEN) P/S Is On The Mark

When you see that almost half of the companies in the Chemicals industry in India have price-to-sales ratios (or "P/S...
分析記事 Feb 06

Neogen Chemicals Limited Just Missed Earnings - But Analysts Have Updated Their Models

It's been a pretty great week for Neogen Chemicals Limited ( NSE:NEOGEN ) shareholders, with its shares surging 16% to...
分析記事 Dec 26

Here's Why Neogen Chemicals (NSE:NEOGEN) Has A Meaningful Debt Burden

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
分析記事 Dec 10

The Returns On Capital At Neogen Chemicals (NSE:NEOGEN) Don't Inspire Confidence

What trends should we look for it we want to identify stocks that can multiply in value over the long term? Firstly...
分析記事 Nov 20

Why Neogen Chemicals' (NSE:NEOGEN) Shaky Earnings Are Just The Beginning Of Its Problems

A lackluster earnings announcement from Neogen Chemicals Limited ( NSE:NEOGEN ) last week didn't sink the stock price...
分析記事 Nov 16

Earnings Miss: Neogen Chemicals Limited Missed EPS By 6.7% And Analysts Are Revising Their Forecasts

Last week, you might have seen that Neogen Chemicals Limited ( NSE:NEOGEN ) released its second-quarter result to the...
分析記事 Sep 20

Investors Appear Satisfied With Neogen Chemicals Limited's (NSE:NEOGEN) Prospects As Shares Rocket 36%

The Neogen Chemicals Limited ( NSE:NEOGEN ) share price has done very well over the last month, posting an excellent...
分析記事 May 08

We Think That There Are More Issues For Neogen Chemicals (NSE:NEOGEN) Than Just Sluggish Earnings

Neogen Chemicals Limited's ( NSE:NEOGEN ) recent weak earnings report didn't cause a big stock movement. We think that...
分析記事 May 05

Earnings Miss: Neogen Chemicals Limited Missed EPS By 24% And Analysts Are Revising Their Forecasts

As you might know, Neogen Chemicals Limited ( NSE:NEOGEN ) last week released its latest full-year, and things did not...
分析記事 Apr 26

After Leaping 27% Neogen Chemicals Limited (NSE:NEOGEN) Shares Are Not Flying Under The Radar

Neogen Chemicals Limited ( NSE:NEOGEN ) shares have had a really impressive month, gaining 27% after a shaky period...
分析記事 Apr 12

Are Neogen Chemicals Limited (NSE:NEOGEN) Investors Paying Above The Intrinsic Value?

Key Insights Using the 2 Stage Free Cash Flow to Equity, Neogen Chemicals fair value estimate is ₹1,238 Current share...
分析記事 Aug 11

Neogen Chemicals (NSE:NEOGEN) Is Increasing Its Dividend To ₹2.75

Neogen Chemicals Limited's ( NSE:NEOGEN ) dividend will be increasing from last year's payment of the same period to...

業績と収益の成長予測

NSEI:NEOGEN - アナリストの将来予測と過去の財務データ ( )INR Millions
日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数
3/31/202927,4601,7912,4672,9504
3/31/202822,2281,3932,1782,6729
3/31/202712,260493-2,8112,1129
3/31/20268,681288-7,872-2,315N/A
12/31/20258,182197N/AN/AN/A
9/30/20257,996261-4,707-1,228N/A
6/30/20257,843336N/AN/AN/A
3/31/20257,776348-1,2171,960N/A
12/31/20247,744494N/AN/AN/A
9/30/20247,374404-2,715915N/A
6/30/20247,057374N/AN/AN/A
3/31/20246,907357-3,319-291N/A
12/31/20236,949330N/AN/AN/A
9/30/20237,168467-1,457149N/A
6/30/20237,032486N/AN/AN/A
3/31/20236,862500-1,341-303N/A
12/31/20226,391513N/AN/AN/A
9/30/20225,855471-2,320-836N/A
6/30/20225,505484N/AN/AN/A
3/31/20224,873446-1,68714N/A
12/31/20214,231383N/AN/AN/A
9/30/20213,757364-2,093311N/A
6/30/20213,445326N/AN/AN/A
3/31/20213,364313-515836N/A
12/31/20203,260293N/AN/AN/A
9/30/20203,231290-246272N/A
6/30/20203,183293N/AN/AN/A
3/31/20203,061287-634-345N/A
12/31/20193,036301N/AN/AN/A
9/30/20192,846262N/A-154N/A
6/30/20192,555225N/AN/AN/A
3/31/20192,391209N/A-37N/A
3/31/20181,612110N/A118N/A
3/31/20171,10177N/A2N/A
3/31/20161,00352N/A86N/A

アナリストによる今後の成長予測

収入対貯蓄率: NEOGENの予測収益成長率 (年間35.1% ) は 貯蓄率 ( 6.9% ) を上回っています。

収益対市場: NEOGENの収益 ( 35.1% ) はIndian市場 ( 16.3% ) よりも速いペースで成長すると予測されています。

高成長収益: NEOGENの収益は今後 3 年間で 大幅に 増加すると予想されています。

収益対市場: NEOGENの収益 ( 27.1% ) Indian市場 ( 10.8% ) よりも速いペースで成長すると予測されています。

高い収益成長: NEOGENの収益 ( 27.1% ) 20%よりも速いペースで成長すると予測されています。


一株当たり利益成長率予想


将来の株主資本利益率

将来のROE: NEOGENの 自己資本利益率 は、3年後には低くなると予測されています ( 10.8 %)。


成長企業の発掘

企業分析と財務データの現状

データ最終更新日(UTC時間)
企業分析2026/05/22 09:10
終値2026/05/22 00:00
収益2026/03/31
年間収益2026/03/31

データソース

企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。

パッケージデータタイムフレーム米国ソース例
会社財務10年
  • 損益計算書
  • キャッシュ・フロー計算書
  • 貸借対照表
アナリストのコンセンサス予想+プラス3年
  • 予想財務
  • アナリストの目標株価
市場価格30年
  • 株価
  • 配当、分割、措置
所有権10年
  • トップ株主
  • インサイダー取引
マネジメント10年
  • リーダーシップ・チーム
  • 取締役会
主な進展10年
  • 会社からのお知らせ

* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用

特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM(Trailing Twelve Month)またはLTM(Last Twelve Month)データとして知られています。詳細はこちら

分析モデルとスノーフレーク

本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドYoutubeのチュートリアルも掲載しています。

シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。

業界およびセクターの指標

私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。

アナリスト筋

Neogen Chemicals Limited 9 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。16

アナリスト機関
null null360 ONE Capital Market Private Limited
null nullAsian Markets Securities Private Limited
Vijayaraghavan SwaminathanAvendus Spark